The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




Verona Pharma plc - VRP Verona Pharma plc Operational Update and Financial Results for the Third Quarter Ended September 30, 2017
07:00 07-Nov-2017  ONE  0.00% View chart
Verona Pharma plc - VRP Verona Pharma Reports Patient Enrollment Progressing Ahead of Schedule in Ongoing Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment
07:00 07-Nov-2017  ONE  0.00% View chart
Verona Pharma plc - VRP Verona Pharma to Present at Two Upcoming Investor Conferences
06:55 31-Oct-2017  ONE  0.00% View chart
Verona Pharma plc - VRP Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to Patients
07:00 27-Sep-2017  ONE  0.00% View chart
Verona Pharma plc - VRP Verona Pharma plc : Miscellaneous
12:46 19-Sep-2017  ONE  0.00% View chart


RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds